Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Status:
Recruiting
Trial end date:
2022-07-15
Target enrollment:
Participant gender:
Summary
The purpose of the study is to describe the safety profile of fingolimod in the Taiwanese
multiple sclerosis population. This study aims to collect the safety data in patients newly
initiated on fingolimod for one year.